BREAKING NEWS
Himanta Biswa Sarma to be next Assam CM
Covid-19: Delhi extends lockdown till May 17, Metro services suspended
Pay only for IPL matches played so far, Star tells worried sponsors & advertisers
‘Operation big cat’: Leopard enters kitchen, trapped after 3 hours of struggle
K’taka govt permits weddings at homes during lockdown
M-cap of eight of top-10 most-valued companies zooms by Rs 81,250.83 cr
Debris of China’s disintegrating rocket falls into Indian Ocean
India records 4,03,738 new COVID-19 cases, 2,42,362 deaths
String of satellites baffles residents, bugs astronomers
Fungal infection cases rising in second phase of pandemic, warn Maha, Gujarat doctors
Bantwal: Two arrested for threatening ASHA worker
Mangaluru: No vaccination programme from May 9 as district exhausts its vaccine stocks
Spike in COVID-19 cases: Bigg Boss Kannada 8 suspended
Positive COVID-19 test report not mandatory for admission in hospitals: Govt
FinMin asks PSU banks to keep high vigil on any attempt to seize funds by Cairn
- Home
- AstraZeneca
Will return to India in a few days, says Adar Poonawalla
”India was there for us and we will be there for them”: President Biden on India’s COVID-19 crisis
EU launches legal action against vaccine-maker AstraZeneca
Biden admin criticised for not releasing surplus COVID-19 vaccines to India
Serum Institute defends vaccine pricing, says initial rates based on advance funding
Pressure mounts on Biden admin to ship AstraZeneca vacc, other medical supplies to India
Questions about AstraZeneca Covid-19 jab linger
Reputation of AstraZeneca’s COVID vaccine marred by missteps
Countries to resume AstraZeneca jabs after EU agency deems it ‘safe’
EU drug agency: No indication AstraZeneca shot caused clots
AstraZeneca reassures safety of COVID-19 vaccine; says no evidence of increased risks
India reviews AstraZeneca Covid-19 vaccine side effects after concerns in Europe
India sending humanitarian assistance to drought-hit Madagascar
El Salvador getting its first vaccine from India
WHO chief raises questions about vaccines
AstraZeneca rejects ‘incorrect’ reports on Covid jab efficacy in elderly
Nepal approves AstraZeneca’s India-made COVID-19 vaccine for emergency use
COVID-19 vaccine to cost $3-4 to govt, $6-8 in pvt mkt says Serum Institute
CDSCO panel approves Oxford COVID-19 vaccine for emergency use
Oxford/AstraZeneca in ‘mix-match’ COVID-19 vaccine trial with Russia’s Sputnik
India ‘pharmacy of world,’ focusing on deeper ties in S&T: Swedish amb
Asian stocks fall amid unease about vaccine development
UK asks regulator to assess AZ-Oxford vaccine amid questions
AstraZeneca manufacturing error clouds vaccine study results
AstraZeneca promises Covid-19 vaccine at cost price worldwide
AstraZeneca, J&J resume Covid-19 vaccine trial in US
Latest Additions
Aatma Nirbhar: Indian Oil Corporation’s role in making India progress towards petroleum self sufficiency
Meghalaya: Mushrooms that glow in the dark
West Bengal: Is the Left on its deathbed?
Maha NCP chief seeks Bharat Ratna for Karmaveer Bhaurao Patil
Strictly follow COVID-19 guidelines, top cop urges people